OptimizeRx (OPRX) EPS (Weighted Average and Diluted) (2017 - 2025)
Historic EPS (Weighted Average and Diluted) for OptimizeRx (OPRX) over the last 15 years, with Q3 2025 value amounting to $0.04.
- OptimizeRx's EPS (Weighted Average and Diluted) rose 10800.0% to $0.04 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.25, marking a year-over-year increase of 11852.26%. This contributed to the annual value of -$1.1 for FY2024, which is 673.12% down from last year.
- OptimizeRx's EPS (Weighted Average and Diluted) amounted to $0.04 in Q3 2025, which was up 10800.0% from $0.08 recorded in Q2 2025.
- Over the past 5 years, OptimizeRx's EPS (Weighted Average and Diluted) peaked at $0.26 during Q4 2024, and registered a low of -$0.5 during Q3 2024.
- Moreover, its 5-year median value for EPS (Weighted Average and Diluted) was -$0.17 (2023), whereas its average is -$0.13.
- As far as peak fluctuations go, OptimizeRx's EPS (Weighted Average and Diluted) tumbled by 876721.38% in 2022, and later skyrocketed by 20746.41% in 2024.
- Quarter analysis of 5 years shows OptimizeRx's EPS (Weighted Average and Diluted) stood at $0.04 in 2021, then tumbled by 151.99% to -$0.02 in 2022, then plummeted by 1209.91% to -$0.24 in 2023, then soared by 207.46% to $0.26 in 2024, then tumbled by 84.49% to $0.04 in 2025.
- Its EPS (Weighted Average and Diluted) was $0.04 in Q3 2025, compared to $0.08 in Q2 2025 and -$0.12 in Q1 2025.